SB3342 101ST GENERAL ASSEMBLY

LRB101 20250 RJF 69790 b

101ST GENERAL ASSEMBLY
State of Illinois
2019 and 2020
SB3342

Introduced 2/14/2020, by Sen. Laura M. Murphy

SYNOPSIS AS INTRODUCED:

30 ILCS 500/25-210 new

Amends the Illinois Procurement Code. Provides that the Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Provides for the adoption of rules.

FISCAL NOTE ACT MAY APPLY

A BILL FOR

AN ACT concerning finance.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 5. The Illinois Procurement Code is amended by adding Section 25-210 as follows:

(30 ILCS 500/25-210 new)

Sec. 25-210. Generic prescription drug contracting. The Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. The Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. The Department shall adopt rules necessary to implement and administer the program created under this Section.